REGN Message Board Post 10886612 | Regeneron...
home / stock / regn / regn message board
(investorshangout)
Posted on: Mar/23/2023 14:05:57
Source: investorshangout
https://investorshangout.com/post/view?id=6551874
whytestocks: $REGN News Article - Dupixent (dupilumab) Demonstrates Potential to Become First Biologic to Treat
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
Market:
Regeneron Pharmaceuticals Inc. Website:
-
2024-05-16 07:15:00 ET Drugmakers outside the biosimilar or generic-medicine market must constantly innovate to be successful over long periods. Some are better at it than others. Eli Lilly (NYSE: LLY) and Regeneron Pharmaceuticals (NASDAQ: REGN) have historically been i...
-
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average ann...
-
If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled CRSwNP, a condition driven in part by underlying type 2 inflammation that obstructs the sinuses and nasal passages and can lead to a loss of sense of smell ...